
Global pharmaceutical company developing, manufacturing, and marketing generic and branded human pharmaceuticals.
Teva Pharmaceutical Industries, founded in 1901 in Israel, is a global leader in the pharmaceutical industry. The company's core mission is to improve health and make quality healthcare accessible through the development, manufacturing, and marketing of generic and branded human pharmaceuticals, along with active pharmaceutical ingredients. Teva's extensive product portfolio spans various therapeutic areas, addressing a wide range of medical needs for patients worldwide.
Notable affiliated individuals include key executives and board members who have guided Teva's strategic direction. The company has garnered significant investment from major global investors, bolstering its market presence. Teva's key achievements include pioneering advancements in generic medicine and expanding its innovative drug portfolio. Its impact is profound, providing affordable healthcare solutions to millions and contributing significantly to global health outcomes.

Bayer Pharmaceuticals
bayer.com

Sun Pharmaceutical Industries

Viatris
viatris.com

Novartis Pharma

AstraZeneca
astrazeneca.com

Boehringer Ingelheim

Leading Pharma
leadingpharma.com

Taiho Pharmaceutical Co.
taiho.co.jp

Amneal Pharmaceuticals
amneal.com

Gilead Sciences
gilead.com
Bristol Myers Squibb
bms.com

Merck & CO INC Cedear EAC 5 RE
merck.com

Pharco Pharmaceuticals
pharco.org

Ferring
ferring.com

GSK
gsk.com
Companies similar to Teva Pharmaceutical Industries include Bayer Pharmaceuticals, Sun Pharmaceutical Industries, Viatris and Novartis Pharma.
Teva Pharmaceutical Industries was founded in 1901.
Teva Pharmaceutical Industries' headquarters is located in Tel Aviv, Tel Aviv District, IL.
Teva Pharmaceutical Industries' most recent funding round was for $100M (USD) in November 2023.
As of Nov 13, 2023, Teva Pharmaceutical Industries has raised a total of $2.7B (USD).
Teva Pharmaceutical Industries has 37,537 employees as of Feb 12, 2024.